NCT05552729 is a Phase 1, PHASE2 clinical trial of Vitamin D in Gastrointestinal Neoplasms, sponsored by Yangzhou University.

Who is sponsoring NCT05552729?

NCT05552729 is sponsored by Yangzhou University.

What drugs are being tested in NCT05552729?

Interventions in NCT05552729: Vitamin D.

What condition does NCT05552729 study?

NCT05552729 studies Gastrointestinal Neoplasms, Cognitive Impairment.

Is NCT05552729 still recruiting?

NCT05552729 is currently status unknown. Last updated 23 September 2022.

Last reviewed 2022-09-23 · How we verify

NCT05552729

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effects of Different Doses of Vitamin D on Cancer-related Cognitive Impairment in Patients With Gastrointestinal Tumors

Status unknown Phase 1, PHASE2 Last updated 23 September 2022

What this trial tests

Phase 1, PHASE2 trial testing Vitamin D in Gastrointestinal Neoplasms in 114 participants. Status unknown.

Timeline

22 September 2022

Primary endpoint
30 December 2022

30 December 2022

Quick facts

Lead sponsor	Yangzhou University
Phase	Phase 1, PHASE2
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	114
Start date	22 September 2022
Primary completion	30 December 2022
Estimated completion	30 December 2022
Sites	1 location across China

Drugs / interventions tested

Vitamin D

Conditions studied

Gastrointestinal Neoplasms — all drugs for Gastrointestinal Neoplasms →
Cognitive Impairment — all drugs for Cognitive Impairment →

Sponsor

Yangzhou University

Who can join

18 and older, any sex, with Gastrointestinal Neoplasms or Cognitive Impairment. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To explore the effect of different doses of vitamin D drugs on gastrointestinal cancer cancer-related cognitive impairment, so as to provide reference and basis for the clinical use of our cognitive function surgery nursing plan for patients with gastrointestinal cancer.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Emerging Role of Neutrophil Extracellular Traps in Gastrointestinal Tumors: A Narrative Review.
Zhang Y, Song J, Zhang Y, Li T, et al · · 2022 · cited 12× · PMID 36613779 · DOI 10.3390/ijms24010334

Verify or expand the search:

Other trials of Vitamin D

Trials testing the same drug.

NCT07366086 — Pediatric Safety Follow-up Study of Prior Treatment With Romosozumab for Osteogenesis Imperfecta · Phase 3 · recruiting
NCT07458815 — Vitamin D for Acute Intracerebral Hemorrhage · NA · not yet recruiting
NCT07491965 — Association Between Benign Paroxysmal Positional Vertigo and Vitamin D Deficiency . · not yet recruiting
NCT07400757 — Statin and Vitamin D Treatment in Patients With Thyroid Eye Disease · NA · not yet recruiting
NCT07293910 — Vonoprazan vs Proton Pump Inhibitor With Vitamin D or Probiotics Based Triple Therapy for Eradication of Helicobacter Py · Phase 2 · recruiting

Other recruiting trials for Gastrointestinal Neoplasms

Currently open trials in the same condition.

NCT07222800 — Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult · Phase 3 · recruiting
NCT07218926 — A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatini · Phase 3 · recruiting
NCT07319364 — A Real-World Study of Fecal Transplants for Cancer Therapy Side Effects · Phase 1 · recruiting
NCT06885034 — A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advance · Phase 1, PHASE2 · recruiting
NCT06996483 — Impact of Oral Versus Intravenous 5-FU-Based Adjuvant Regimens on Sleep Quality and Depression in Patients With Gastroin · recruiting

Other Yangzhou University trials

Trials by the same sponsor.

NCT06517069 — Effect of TEAS Combined With Oxycodone on Postoperative Visceral Pain in Gynecologic Laparoscopic Patients · NA · recruiting
NCT05936918 — Application of Transcutaneous Electrical Acupoint Stimulation in Laparoscopic Cholecystectomy · NA · unknown
NCT05909696 — Median Effective Dose of Rocuronium for the Prevention of Myofibrillation Caused by the Injection of Succinylcholine · NA · completed
NCT05932485 — Effect of Stellate Ganglion Block on New Atrial Fibrillation After Coronary Artery Bypass Grafting · NA · completed
NCT06456710 — Effect of a Psychological Intervention on Stigma: a Randomized Controlled Study · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05552729 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Yangzhou University
Last refreshed: 23 September 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05552729.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing